A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder-Reference-Cited by-同舟云学术

A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder

Published:1993-01 Issue:12 Volume:29 Page:1672-1676
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Witjes J.A.,Meijden A.P.M.v.d.,Witjes W.P.J.,Doesburg W.,Schaafsma H.E.,Debruyne F.M.J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Long-term mitomycin C instillation after resection of superficial bladder carcinoma: influence on recurrence, progression, and survival;Huland;J Urol,1984

2. Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients;Huland;J Urol,1990

3. BCG immunotherapy;Lamm;J Urol,1982

4. Role of intravesical mitomycin in management of superficial bladder tumors;Bracken;Urology,1980

5. Carcinoma in situ;Lamm;Urol Clin N Am,1992

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations;BJU International;2024-02-25

2. Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette–Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis;Frontiers in Oncology;2023-05-12

3. Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition);Military Medical Research;2022-08-17

4. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer;Journal for ImmunoTherapy of Cancer;2021-07

5. Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer;Cochrane Database of Systematic Reviews;2020-01-08